Skip to main content
NIH funding notice RFA-DK-25-022

Precision Medicine for Type 1 Diabetic Nephropathy (U01 Clinical Trial Not Allowed)

Closed on December 10, 2024.

Posted
September 26, 2024
Close date
December 10, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
2
2 new
Median first-year cost
$800,694
$1,601,388 in all
Institutions
2
2 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. MAYO CLINIC ROCHESTER1
  2. UNIVERSITY OF WASHINGTON1

Most frequent study sections

  1. Special Emphasis Panel (ZDK1 GRB-M (M1))2
2 awards under RFA-DK-25-022 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2025KPMP in Type 1 Diabetes: A UW Medicine Collaboration1U01DK144965-01Bjornstad, PetterDe Boer, Ian HUNIVERSITY OF WASHINGTON, WAFirst-year cost $810,823Study section ZDK1
FY2025T1D-DN KPMP Urban Rural (T1D-DN KUR) Recruitment Site1U01DK144994-01Kudva, Yogish C.Kukla, AleksandraMAYO CLINIC ROCHESTER, MNFirst-year cost $790,565Study section ZDK1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-DK-25-022: Precision Medicine for Type 1 Diabetic Nephropathy (U01 Clinical Trial Not Allowed) | ScienceDex | ConductScience